. National Heart, Lung, and Blood Institute (2000)Morbidity and mortality: 2000 chartbook on cardiovascular, lung, and blood diseases. US Department of Health and Human Services, Public Health Service, National Institutes of Health. Bethesda, MD:
National Center for Health Statistics. Vital health statistics: plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94.1994,1-406 Centers for Disease Control and Prevention. Atlanta, GA:
Mannino, DM, Gagnon, RC, Petty, TL, et al Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994.Arch Intern Med2000;160,1683-1689
Global Initiative for Chronic Obstructive Lung Disease.. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop report executive summary. 2001; National Institutes of Health. Bethesda, MD: NIH Publication No. 2701.
Global Initiative for Asthma.. Global strategy for asthma management and prevention. 2002; National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, MD: NIH Publication No. 02–3659.
Mannino, DM, Brown, C, Giovino, GA Obstructive lung disease deaths in the United States from 1979 through 1993: an analysis using multiple-cause mortality data.Am J Respir Crit Care Med1997;156,814-818
Mannino, DM COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.Chest2002;121(suppl),121S-126S
American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema: a statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases.Am Rev Respir Dis1962;85,762-768
Burrows, B, Bloom, JW, Traver, GA, et al The course and prognosis of different forms of chronic airways obstruction in a sample from the general population.N Engl J Med1987;317,1309-1314
American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med1995;152,S77-S121
Mahler, DA, Donohue, JF, Barbee, RA, et al Efficacy of salmeterol xinafoate in the treatment of COPD.Chest1999;115,957-965
Donohue, JF, van Noord, JA, Bateman, ED, et al A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.Chest2002;122,47-55
National Asthma Education and Prevention Program.. Expert panel report 2: guidelines for the diagnosis and management of asthma. 1997; National Institutes of Health. Bethesda MD: NIH Publication No. 97–4051.
Kerstjens, HAM, Brand, PLP, Hughes, MD, et al A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease: the Dutch Chronic Non-Specific Lung Disease Study Group.N Engl J Med1992;327,1413-1419
Orie, NGM, Sluiter, HJ, de Vries, K, et al The host factor in bronchitis. Orie, NGM Sluiter, HJ eds.Bronchitis1961,43-59 Royal van Gorcum. Assen, the Netherlands:
Silverman, EK, Palmer, LJ, Mosley, JD, et al Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease.Am J Hum Genet2002;70,1229-1239